Our Solutions We’re on a mission to use Artificial Intelligence to transform healthcare as we know it. OKRA.ai’s systems support life sciences companies to better enable the drive of personalised medicine across the globe. We bring AI to life through the OKRA.ai Brain: A new era in intelligence and decision-making that supports the successful commercialisation of pipeline assets with AI insights. OKRA.ai combines advanced AI with a hybrid explainability to deliver real-time insights, including predictions and suggestions to support commercial engagement, help identify medical unmet needs, and assist market access teams with regulatory submissions for new assets when considering the future price and benefit decisions. We aim to drive the right drug to the right patient with humanised and understandable AI outputs. Our unique solutions bring AI to life. We provide insights that you can’t ignore; where suggestions are based on future predictions and where each suggestion is evidenced. We consider all data along with successes and failures of the past to help you shape the future. To unlock the latent value in an ever-increasing array of datasets, OKRA.ai’s AI platform represents an engine with unique components to support optimal and efficient decision-making. OKRA.ai curates and enhances a valuable data lake for insights generation and leverages advanced feature extraction algorithms to understand the characteristics that are critical for value creation. At OKRA.ai we are fostering a new generation of Artificial Intelligence (AI) solutions that support the healthcare ecosystem. Our solutions are implemented by top pharma companies throughout the product pipeline to empower employees through integrated insights that support decision-making around complex problems. OKRA’s AI solutions are translating large clinical, scientific and commercial data sets into actionable insights that employees in life science companies can easily query at their desks or whilst on the move. “We’re on a mission to use Artificial Intelligence to transform healthcare as we know it.” About Dr Loubna Dr Loubna Bouarfa is the founder and CEO of OKRA. ai – a leading artificial intelligence (AI) company for life sciences, that supports the industry in bringing the right drug to the right patient at speed. Loubna, a member of the European Union HighLevel Expert Group on AI, was in 2018 named an MIT Technology Review Top Innovator Under 35 and a Forbes Top 50 Women In Tech. In 2019 she accepted the CEO of the year award at the Cambridge Independent Science and Technology Awards, along with the Best Female-Led Startup at the StartUp Europe Awards. 2022 she has been selected as a European Young Leader (EYL40). About OKRA.ai OKRA.ai began with our founder and CEO Dr Loubna Bouarfa, who has spent the last 15 years researching the field of AI and implementing it across healthcare. In 2007, Loubna applied her research to the operating table, predicting surgical errors in real-time – alerting surgeons to potential errors in order to prevent them. This paper has become the most cited study of its kind in the field of machine learning for surgical workflows and paved the way for her to make the move from research to entrepreneurship. Loubna founded OKRA.ai in 2015 as a leading artificial intelligence (AI) company transforming life sciences operations through the use of AI solutions. OKRA. ai has created a state-of-the-art, AI solution suite that compiles healthcare data from multiple sources, with coverage across hundreds of therapeutic areas, thousands of clinical trials and publications, millions of medically relevant free text and billions of data points that are specific to patient demographics. We are incredibly proud to be based in one of the top tech cities in Europe. Cambridge is a hub of creativity, and innovativeness and rich in cognitive diversity, ideal for the cutting-edge work we do here at OKRA.ai. www.ceotodaymagazine.com CEO Today United Kingdom Awards 2023 37
RkJQdWJsaXNoZXIy Mjk3Mzkz